HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial.

AuthorsPaolo Ghia, Steven E Coutre, Bruce D Cheson, Jacqueline C Barrientos, Peter Hillmen, Andrew R Pettitt, Andrew D Zelenetz, Sanatan Shreay, Michael Hallek, Richard R Furman
JournalHaematologica (Haematologica) Vol. 105 Issue 10 Pg. e519 (10 01 2020) ISSN: 1592-8721 [Electronic] Italy
PMID33054096 (Publication Type: Clinical Trial, Phase III, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Purines
  • Quinazolinones
  • idelalisib
Topics
  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy)
  • Purines (therapeutic use)
  • Quality of Life
  • Quinazolinones (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: